CN110801043A - Microcapsule for improving immunity of chronic disease patient and preparation method thereof - Google Patents
Microcapsule for improving immunity of chronic disease patient and preparation method thereof Download PDFInfo
- Publication number
- CN110801043A CN110801043A CN201911178753.0A CN201911178753A CN110801043A CN 110801043 A CN110801043 A CN 110801043A CN 201911178753 A CN201911178753 A CN 201911178753A CN 110801043 A CN110801043 A CN 110801043A
- Authority
- CN
- China
- Prior art keywords
- microcapsule
- chia seed
- core material
- immunity
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 230000036039 immunity Effects 0.000 title claims abstract description 17
- 208000017667 Chronic Disease Diseases 0.000 title claims description 19
- 235000020235 chia seed Nutrition 0.000 claims abstract description 54
- 235000019198 oils Nutrition 0.000 claims abstract description 36
- 239000011162 core material Substances 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920000856 Amylose Polymers 0.000 claims abstract description 11
- 229920002261 Corn starch Polymers 0.000 claims abstract description 11
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 11
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 11
- 240000006394 Sorghum bicolor Species 0.000 claims abstract description 11
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims abstract description 11
- 229920002472 Starch Polymers 0.000 claims abstract description 11
- 239000008120 corn starch Substances 0.000 claims abstract description 11
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 11
- 239000008107 starch Substances 0.000 claims abstract description 11
- 235000019698 starch Nutrition 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 8
- 230000001684 chronic effect Effects 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 102000011632 Caseins Human genes 0.000 claims abstract description 3
- 108010076119 Caseins Proteins 0.000 claims abstract description 3
- 229940099112 cornstarch Drugs 0.000 claims abstract description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 3
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 3
- 229940080237 sodium caseinate Drugs 0.000 claims abstract description 3
- 239000000839 emulsion Substances 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 11
- 238000001694 spray drying Methods 0.000 claims description 9
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000010008 shearing Methods 0.000 claims description 7
- -1 sucrose ester Chemical class 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 3
- 240000007472 Leucaena leucocephala Species 0.000 claims description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 239000008236 heating water Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 239000004519 grease Substances 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 33
- 238000005303 weighing Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000004426 flaxseed Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 241001411320 Eriogonum inflatum Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention particularly relates to a microcapsule for improving the immunity of a chronic patient and a preparation method thereof, belonging to the field of food processing. The microcapsule consists of a solid and water, wherein the solid comprises the following components in parts by weight: 30-45% of core material; 53-68% of wall material; and 2% of an emulsifier. The core material is chia seed oil and chia seed powder; the wall material is one or a mixture of more of high amylose corn starch, sodium caseinate, fructo-oligosaccharide, sorghum starch and maltodextrin. The prepared microcapsule has good stability, high solubility and good grease embedding effect; it is another object of the present invention to provide a process for producing microcapsules which is simple and feasible and whose process is easy to control. The microcapsule of the invention is suitable for various chronic patients to take.
Description
Technical Field
The invention particularly relates to a microcapsule for improving the immunity of a chronic patient and a preparation method thereof, belonging to the field of food processing.
Background
The microcapsule is widely applied in different fields of food, biotechnology, chemical industry, medicine and the like, and has unique advantages compared with other technologies. Microencapsulation physically encapsulates the sensitive components in a coating to protect these components or the "core material" from adverse reactions (e.g., light, oxygen, temperature, humidity); optimizing the physical properties (such as odor, appearance, solubility) of the core material itself; the stability of the core material is improved; isolating immiscible or interactive substances.
Chronic diseases, a generalized collective term for diseases whose etiology is complex and some of which have not been completely identified. Common chronic diseases mainly include cardiovascular and cerebrovascular diseases, cancer, diabetes and chronic respiratory diseases, wherein the cardiovascular and cerebrovascular diseases comprise hypertension, stroke and coronary heart disease. The chronic diseases mainly cause the damage of important organs such as brain, heart, kidney and the like, are easy to cause disability, influence the labor capacity and the life quality, are extremely expensive in medical cost, and increase the economic burden of society and families.
Chia seed is rich in nutrition, fat, high-quality protein, dietary fiber and various minerals. The ratio of essential amino acids to total amino acids in chia seed protein is superior to common peanut protein, linseed protein and walnut protein, and is similar to soybean protein. The amino acid composition in chia seed protein is close to the ideal mode recommended by FAO/WHO, has higher edible value and is a high-quality vegetable protein source. In addition, chia seed is rich in vitamin E, carotenoid, polyphenol compounds and other antioxidant active substances, and has high physiological activity and application value.
Compared with other vegetable oils, the α -linolenic acid (ALA) content of chia seed oil is far ahead (50.6 percent of linseed), rape (8.1 percent), soybean (7.6 percent) and sunflower (1.8 percent)).
Disclosure of Invention
According to the characteristics of chia seed oil and chronic diseases, the invention provides the microcapsule for improving the immunity of chronic patients, and the prepared microcapsule has good stability, high solubility and good grease embedding effect by adopting chia seed powder and chia seed oil; another object of the invention is to provide a simple and feasible production method of chia seed oil microcapsules, wherein the process is easy to control.
A microcapsule for improving the immunity of patients with chronic diseases consists of a solid and water, wherein the solid comprises the following components in parts by weight:
30-45% of core material;
53-68% of wall material;
and 2% of an emulsifier.
The core material is chia seed oil and chia seed powder;
the wall material is one or a mixture of more of high amylose corn starch, sodium caseinate, fructo-oligosaccharide, sorghum starch and maltodextrin.
The emulsifier is one or more of chia seed gum, monoglyceride, sucrose ester, polyoxyethylene sorbitan fatty acid ester, and acacia.
The ratio of the solid to the water is 1: 3.
The preparation method of the chia seed oil microcapsule comprises the following steps:
(1) preparation of a core material: adding chia seed powder into chia seed oil, and fully mixing; preparing emulsion, namely the core material;
(2) dissolving: heating water to 65-70 deg.C; adding wall materials and an emulsifier into water in sequence according to the weight proportion, and fully stirring;
(3) homogenizing: after the core material is added, high-speed shearing is carried out for 5-10min, the shearing rotating speed is 10000-;
(4) spray drying: the inlet temperature is 175-.
The prepared microcapsule for improving the immunity of patients with chronic diseases is applied to the preparation of medicines for treating chronic diseases.
The invention has the advantages that:
1. high nutritive value
The chia seed oil is rich in unsaturated fatty acid, wherein the content of α -linolenic acid is over 60 percent, and the chia seed oil can meet the special nutritional requirements of various chronic patients and can be used as an oil component suitable for the chronic patients to eat.
2. Good oxidation resistance
The microcapsule product prepared by the invention has the characteristics of less loss of effective components, uniform particle size, good stability, easy dissolution, strong oxidation resistance and the like. The microcapsule shows ideal antioxidant effect, and the results of accelerated oxidation tests show that the oxidation stability of the chia seed oil microcapsule is far higher than that of non-embedded chia seed oil. On the 7 th day of the accelerated oxidation experiment, the peroxide value of the microcapsule product is far lower than that of the uninsulated chia seed oil, the oxidation stability is good, and the shelf life of the functional oil can be prolonged.
3. Wide application
Can be widely applied to the field of food, including the processing production of special medical food.
Detailed Description
Example 1
The preparation process of the core material comprises the following steps: firstly, adding chia seed oil into a container, then adding chia seed powder, and fully mixing; making into emulsion, packaging, and storing at appropriate temperature.
A preparation process of a microcapsule for improving the immunity of patients with chronic diseases comprises the following steps: weighing 20g of sorghum starch, 18g of high amylose corn starch, 31.15g of maltodextrin, 1.5g of monoglyceride and 0.5g of chia seed gum, and fully stirring and dissolving at 65 ℃ to 500 mL; then 28.85g of core material is added, and the mixture is sheared for 5 minutes at high speed under the condition of 10000 revolutions per minute; homogenizing the emulsion with a high-pressure homogenizer under 30MPa for 3 times; finally, the inlet temperature of spray drying is 175-.
Example 2
Preparation of a core material: the preparation process of the core material comprises the following steps: firstly, adding chia seed oil into a container, then adding chia seed powder, and fully mixing; making into emulsion, packaging, and storing at appropriate temperature.
A preparation process of a microcapsule for improving the immunity of patients with chronic diseases comprises the following steps: weighing 10g of sorghum starch, 10g of high amylose corn starch, 48g of maltodextrin, 1.55g of monoglyceride and 0.45g of chia seed gum, and fully stirring and dissolving the mixture to 500mL at the temperature of 65 ℃; then 30g of core material is added, and the mixture is sheared for 5 minutes at a high speed under the condition of 10000 revolutions per minute; homogenizing the emulsion with a high-pressure homogenizer under 30MPa for 3 times; finally, the inlet temperature of spray drying is 175-.
Example 3
The preparation process of the core material comprises the following steps: firstly, adding chia seed oil into a container, then adding chia seed powder, and fully mixing; making into emulsion, packaging, and storing at appropriate temperature.
A preparation process of a microcapsule for improving the immunity of patients with chronic diseases comprises the following steps: weighing 10g of sorghum starch, 30g of high amylose corn starch, 18g of maltodextrin, 1g of monoglyceride and 1g of chia seed gum, and fully stirring and dissolving at 65 ℃ to 500 mL; then adding 40g of core material, and shearing at high speed for 5 minutes under the condition of 10000 revolutions per minute; homogenizing the emulsion with a high-pressure homogenizer under 30MPa for 3 times; finally, the inlet temperature of spray drying is 175-.
Comparative example 1
The preparation process of the core material comprises the following steps: firstly, adding chia seed oil into a container, adding 1.55g of monoglyceride and 0.45g of flaxseed gum, fully stirring, and then adding chia seed powder. Making into emulsion, packaging, and storing at appropriate temperature.
A preparation process of a microcapsule for improving the immunity of patients with chronic diseases comprises the following steps: weighing 10g of sorghum starch, 10g of high amylose corn starch and 48g of maltodextrin, and fully stirring and dissolving the sorghum starch, the high amylose corn starch and the maltodextrin to 500mL at the temperature of 65 ℃; then 30g of core material is added, and the mixture is sheared for 5 minutes at a high speed under the condition of 10000 revolutions per minute; homogenizing the emulsion with a high-pressure homogenizer under 30MPa for 3 times; finally, the inlet temperature of spray drying is 175-.
Comparative example 2
Preparation of a core material: the preparation process of the core material comprises the following steps: firstly, adding chia seed oil into a container, then adding chia seed powder, and fully mixing; making into emulsion, packaging, and storing at appropriate temperature.
A preparation process of a microcapsule for improving the immunity of patients with chronic diseases comprises the following steps: weighing 10g of sorghum starch, 15.95g of high amylose corn starch, 44.7g of maltodextrin and 0.5g of chia seed gum, and fully stirring and dissolving at 65 ℃ to 500 mL; then 28.85g of core material is added, and the mixture is sheared for 5 minutes at high speed under the condition of 10000 revolutions per minute; homogenizing the emulsion with a high-pressure homogenizer under 30MPa for 3 times; finally, the inlet temperature of spray drying is 175-.
Comparative example 3
Preparation of a core material: the preparation process of the core material comprises the following steps: firstly, adding chia seed oil into a container, then adding chia seed powder, and fully mixing; making into emulsion, packaging, and storing at appropriate temperature.
A preparation process of a microcapsule for improving the immunity of patients with chronic diseases comprises the following steps: weighing 20g of sorghum starch, 60g of high amylose corn starch, 58.5g of maltodextrin, 1.8g of monoglyceride and 1.2g of chia seed gum, and fully stirring and dissolving the mixture to 500mL at the temperature of 65 ℃; then adding 40g of core material, and shearing at high speed for 5 minutes under the condition of 10000 revolutions per minute; homogenizing the emulsion with a high-pressure homogenizer under 30MPa for 3 times; finally, the inlet temperature of spray drying is 175-.
Comparative example 4
Preparation of a core material: the preparation process of the core material comprises the following steps: firstly, adding chia seed oil into a container, then adding chia seed powder, and fully mixing; making into emulsion, packaging, and storing at appropriate temperature.
A preparation process of a microcapsule for improving the immunity of patients with chronic diseases comprises the following steps: weighing 10g of sorghum starch, 5g of high amylose corn starch, 50g of maltodextrin, 1.2g of monoglyceride and 0.8g of chia seed gum, adding 20g of core material, and fully stirring and dissolving at 65 ℃ to 500 mL; shearing at high speed for 5 minutes under the condition of 10000 r/min; homogenizing the emulsion with a high-pressure homogenizer under 30MPa for 3 times; finally, the inlet temperature of spray drying is 175-.
Examples of the effects of the invention
Effect example 1
The experiments on the functional oils and fats in different proportions, which contribute to the improvement of diabetes, were as follows:
selecting healthy mice with the same variety and age, and constructing a hyperlipidemia model;
control group: feeding common feed
Example set: feeding common feed and chia seed oil microcapsules in examples 1-3 and comparative examples 1-4;
wherein the feed feeding amount of each group is identical; and (4) measuring blood fat after feeding for 3 months.
And (3) determining the blood fat of the mouse: after the mice fasted overnight for 12 hours without water prohibition, the heart was bled and the blood lipid level was measured using a full-automatic biochemical analyzer.
Blood lipid measurement of mouse (unit mmol/L)
Effect example two
The experiments on the functional oils and fats in different proportions, which contribute to the improvement of diabetes, were as follows:
selecting healthy mice with the same variety and age, and constructing a diabetes model;
control group: feeding common feed
Example set: feeding common feed and chia seed oil microcapsules in examples 1-3 and comparative examples 1-4;
wherein the feed feeding amount of each group is identical, and blood glucose is measured after feeding for 3 months.
Blood glucose measurement results (unit mg/dL)
Effect example III
The embedding rates of the functional oil and fat microcapsules prepared in examples 1 to 3 and comparative examples 2 to 4 were measured, and the results were as follows:
effect example four
The stability of the functional oil microcapsules prepared by the invention is evaluated: the method comprises the following steps: and (3) dissolving the functional oil microcapsules by using water at the temperature of 80 ℃ to obtain a 10% functional oil microcapsule solution, uniformly stirring the solution by using a glass rod, standing for 1h after the solution is uniformly stirred, and observing the stability of the emulsion and whether floating oil appears on the surface. The test results were as follows:
effect example five
The solubility of the chia seed oil microcapsules prepared by the invention is evaluated: the method comprises the following steps: accurately weighing 5g chia seed oil microcapsule sample, uniformly pouring into a 50mL beaker, dissolving the microcapsule with 38mL of distilled water at 25-30 ℃, transferring into a 50mL centrifuge tube, screwing a bottle stopper, placing in a centrifuge, centrifuging for 10min at 4000 r min-1, and pouring out the supernatant. Adding 38mL of distilled water at 25-30 ℃, fully shaking to dissolve the precipitate again, centrifuging for 10min at 4000 r min-1, pouring out the supernatant, washing the precipitate with a small amount of distilled water into an evaporation dish which is dried to constant weight, and placing the evaporation dish into an oven at 105 ℃ to be dried to constant weight. The solubility is calculated as:
solubility =1- [ (W)2-W1)×100%][(1-A)×W0]-1
Wherein, W0Is the microcapsule sample mass, W1For evaporating dish mass, W2The mass of the evaporating dish plus the mass of insoluble matter, and A is the water content of the microcapsule.
Therefore, the chia seed oil microcapsule provided by the invention has good solubility.
Effect example six
And simultaneously putting the chia seed oil and the chia seed oil microcapsule into an oven at 63 +/-2 ℃ to perform an accelerated oxidation experiment, and sampling every 24 hours to determine the change of the peroxide value. The peroxide number was determined according to GB 5009.227-2016.
Peroxide number measurement (unit mmol/Kg)
Group of | Day 0 | 3 days | 7 days |
Crude oil | 2.085 | 8.281 | 21.245 |
Microcapsules | 2.467 | 3.427 | 5.641 |
It should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications therefrom are within the scope of the invention.
Claims (6)
1. The microcapsule for improving the immunity of chronic patients is characterized by comprising a solid and water, wherein the solid comprises the following components in parts by weight:
30-45% of core material;
53-68% of wall material;
and 2% of an emulsifier.
2. The core material is chia seed oil and chia seed powder;
the wall material is one or a mixture of more of high amylose corn starch, sodium caseinate, fructo-oligosaccharide, sorghum starch and maltodextrin.
3. The microcapsule according to claim 1, wherein the emulsifier is chia seed gum and one or more of monoglyceride, sucrose ester, polyoxyethylene sorbitan fatty acid ester, and acacia.
4. The microcapsule according to claim 1, wherein the ratio of the solid to the water is 1: 3.
5. The method for preparing microcapsules for enhancing immunity of patients with chronic diseases according to claim 1, comprising the steps of:
(1) preparation of a core material: adding chia seed powder into chia seed oil, and fully mixing; preparing emulsion, namely the core material;
(2) dissolving: heating water to 65-70 deg.C; adding wall materials and an emulsifier into water in sequence according to the weight proportion, and fully stirring;
(3) homogenizing: after the core material is added, high-speed shearing is carried out for 5-10min, the shearing rotating speed is 10000-;
(4) spray drying: the inlet temperature is 175-.
6. Use of microcapsules for enhancing the immunity of patients suffering from chronic diseases, prepared according to claim 4, for the preparation of a medicament for the treatment of chronic diseases.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911178753.0A CN110801043A (en) | 2019-11-27 | 2019-11-27 | Microcapsule for improving immunity of chronic disease patient and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911178753.0A CN110801043A (en) | 2019-11-27 | 2019-11-27 | Microcapsule for improving immunity of chronic disease patient and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110801043A true CN110801043A (en) | 2020-02-18 |
Family
ID=69491524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911178753.0A Pending CN110801043A (en) | 2019-11-27 | 2019-11-27 | Microcapsule for improving immunity of chronic disease patient and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110801043A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116458646A (en) * | 2023-04-23 | 2023-07-21 | 山东康乐医疗管理有限公司 | Production method of compound nutrient |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104323282A (en) * | 2014-11-05 | 2015-02-04 | 潘炳阳 | Soft capsule with chia seed oil and preparation method thereof |
CN105996040A (en) * | 2016-05-20 | 2016-10-12 | 福建师范大学 | Microcapsule powder and preparation method thereof |
CN109452378A (en) * | 2018-12-29 | 2019-03-12 | 武汉轻工大学 | It is a kind of to handle the method for being rich in the grease of alpha-linolenic acid and grease and its application |
CN110063500A (en) * | 2019-05-24 | 2019-07-30 | 山东省立医院 | A kind of low GI value biodiesel microcapsules and preparation method thereof |
CN110169578A (en) * | 2019-05-24 | 2019-08-27 | 山东省农业科学院农产品研究所 | A kind of biodiesel microcapsules and preparation method thereof containing odd sub- seed glue |
-
2019
- 2019-11-27 CN CN201911178753.0A patent/CN110801043A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104323282A (en) * | 2014-11-05 | 2015-02-04 | 潘炳阳 | Soft capsule with chia seed oil and preparation method thereof |
CN105996040A (en) * | 2016-05-20 | 2016-10-12 | 福建师范大学 | Microcapsule powder and preparation method thereof |
CN109452378A (en) * | 2018-12-29 | 2019-03-12 | 武汉轻工大学 | It is a kind of to handle the method for being rich in the grease of alpha-linolenic acid and grease and its application |
CN110063500A (en) * | 2019-05-24 | 2019-07-30 | 山东省立医院 | A kind of low GI value biodiesel microcapsules and preparation method thereof |
CN110169578A (en) * | 2019-05-24 | 2019-08-27 | 山东省农业科学院农产品研究所 | A kind of biodiesel microcapsules and preparation method thereof containing odd sub- seed glue |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116458646A (en) * | 2023-04-23 | 2023-07-21 | 山东康乐医疗管理有限公司 | Production method of compound nutrient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7265787B2 (en) | Methods, compositions, and devices for meeting dietary fatty acid requirements | |
CN105053276B (en) | Preparation method without sucrose functionality peony seed oil powdered oil | |
Kouamé et al. | Novel trends and opportunities for microencapsulation of flaxseed oil in foods: A review | |
US8343753B2 (en) | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae | |
CN102283386B (en) | Composite camellia oil health care product with function of reducing blood fat and preparation method thereof | |
CN105104584B (en) | The preparation method of peony seed oil powdered oil containing active peptide | |
CN104000244B (en) | A kind of krill fat capsule and preparation method thereof | |
KR20200128656A (en) | Lysophosphatidylcholine composition | |
CN105079009B (en) | Prevention and/or the composition for the treatment of cardiovascular and cerebrovascular disease | |
CN107441217B (en) | Oral emulsion rich in alpha-linolenic acid and preparation method thereof | |
CN113287659A (en) | Functional structural oil and preparation method and application thereof | |
CN110801043A (en) | Microcapsule for improving immunity of chronic disease patient and preparation method thereof | |
Mens et al. | Enriching table eggs with n-3 polyunsaturated fatty acids through dietary supplementation with the phototrophically grown green algae Nannochloropsis limnetica: effects of microalgae on nutrient retention, performance, egg characteristics and health parameters | |
CN110810844A (en) | Functional grease microcapsule for improving nephropathy and preparation method and application thereof | |
TW200522939A (en) | Composition having action preventing or alleviating symptoms or diseases due to aging of blood vessels | |
CN105616557A (en) | Self-emulsifying soft capsule with peony seed oil and application of self-emulsifying soft capsule to preparing blood fat reducing healthcare products or medicines | |
CN106798335A (en) | The application of medium chain triglyceride | |
CN107404905A (en) | astaxanthin composition (IV) | |
CN109156545A (en) | A kind of composition and preparation method thereof with regulating blood lipid action | |
CN112890066A (en) | Solid beverage capable of regulating blood fat, resisting fatigue and enhancing immunity and application thereof | |
CN110915997A (en) | Functional powdered oil for improving animal immunity and preparation method thereof | |
US20200147147A1 (en) | Micron fish oil composition, and preparation process and uses thereof | |
CN116098289B (en) | Preparation method of DHA-containing rice bran-based carrier | |
CN105831768A (en) | Composition for auxiliarily reducing blood fat, preparation method and application thereof | |
Soro et al. | Improvement of the nutritional quality of a local germinated sorghum-based complementary food: effect of sorghum (Sorghum bicolor) and shea caterpillar (Cirina butyrospermie) combination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200218 |